Cleveland Biolabs (CBLI) Reports Q2 Loss of $1.12
Tweet
Share
E-mailGet Alerts CBLI Hot Sheet
Price: $3.17 --0%
Financial Fact:
LOSS FROM OPERATIONS: -714.13K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
LOSS FROM OPERATIONS: -714.13K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Cleveland Biolabs (NASDAQ: CBLI) reported Q2 EPS of ($1.12), versus ($1.53) reported last year. Revenue for the quarter came in at $329.9 million, versus $562.1 million reported last year.
For earnings history and earnings-related data on Cleveland Biolabs (CBLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Sypris Solutions (SYPR) Reports Q2 Loss of $0.14
- EXL closes $1 billion credit facility, up from $600 million
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
